
Verrica Pharmaceuticals, Inc.
Verrica Pharmaceuticals, Inc. (VRCA) Received a Third Complete Response Letter from the FDA relating to its New Drug Application for VP-102 Robbins LLP is investigating
Verrica Pharmaceuticals, Inc. (VRCA) Received a Third Complete Response Letter from the FDA relating to its New Drug Application for VP-102 Robbins LLP is investigating
Robbins LLP Investigates Microstrategy, Inc. (MSTR) on Behalf of Shareholders Robbins LLP announces that it is investigating Microstrategy, Inc. (NASDAQ: MSTR) to determine whether certain
Apyx Medical Corporation (APYX) Used its Products for Off-Label Indications A shareholder filed a class action on behalf of all persons or entities that purchased
Teladoc Health, Inc. Misses First Quarter Financial Estimates Due to $6.6 Billion Non-Cash Goodwill Impairment Charge to Increased Competition A shareholder filed a class
Energy Transfer LP (ET) Fined $40 Million for Polluting of Tuscarawas River by its Third-Party Contractor A shareholder filed a class action on behalf of
IonQ, Inc. (IONQ) Failed to Disclose Material Information about the Development and Effectiveness of its Computers to Shareholders A shareholder filed a class action on
Pegasystems, Inc. (PEGA) found guilty of stealing its competitor’s trade secrets A shareholder filed a class action on behalf of all persons and entities that
Okta, Inc. (OKTA) Failed to Disclose Security Breach A shareholder filed a class action on behalf of all persons and entities that purchased or
Enservco Corporation (ENSV) Delays Filing its Year End and Quarterly Reports Due to Accounting Errors A shareholder filed a class action on behalf of all
Attorney Advertising. Past results do not guarantee a similar outcome.
Disclaimer | Site Map | Privacy Policy
© 2021 – Robbins LLP